## Core Concept
Familial hypercholesterolemia (FH) is a genetic disorder characterized by very high levels of low-density lipoprotein cholesterol (LDL-C), often leading to premature cardiovascular disease. The management of FH involves the use of lipid-lowering therapies to reduce LDL-C levels.

## Why the Correct Answer is Right
The correct answer, **Ezetimibe + Statin or PCSK9 inhibitors**, is considered the drug of choice for familial hypercholesterolemia because it effectively reduces LDL-C levels through multiple mechanisms. **Statins** inhibit HMG-CoA reductase, a key enzyme in cholesterol biosynthesis in the liver, leading to a reduction in LDL-C production. **Ezetimibe** works by inhibiting the intestinal absorption of cholesterol, further reducing the amount of cholesterol available for incorporation into LDL particles. **PCSK9 inhibitors** are monoclonal antibodies that target and inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that degrades LDL receptors on the liver cells, thereby increasing the number of LDL receptors available to clear LDL-C from the bloodstream.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not specify a combination or a class of drugs known to be effective in significantly lowering LDL-C levels in patients with familial hypercholesterolemia.
- **Option B:** This option is incorrect as it only mentions one class of drugs, which might not be sufficient on its own for managing the high LDL-C levels seen in FH.
- **Option C:** This option is incorrect because, similar to Option B, it might not provide a sufficient reduction in LDL-C levels for patients with familial hypercholesterolemia.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with familial hypercholesterolemia often require combination therapy to achieve significant reductions in LDL-C levels and to prevent or delay the onset of cardiovascular events. Early and aggressive treatment is crucial in managing this condition.

## Correct Answer Line
**Correct Answer: D. Ezetimibe + Statin or PCSK9 inhibitors**